Clinical trial
Phase II Study of Combidex in Axillary Node Staging in Breast Cancer
NCT00107484 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Combidex in Axillary Node Staging in Breast Cancer
- Lead sponsor
- Virginia Commonwealth University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2005
- Completion date
- October 31, 2006
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer